SNY
$48.2
Revenue | $13170Mn |
Net Profits | $2802Mn |
Net Profit Margins | 21.28% |
Sanofi’s revenue fell -6.97% since last year same period to $13170Mn in the Q3 2025. On a quarterly growth basis, Sanofi has generated 22.68% jump in its revenue since last 3-months.
Sanofi’s net profit fell -0.46% since last year same period to $2802Mn in the Q3 2025. On a quarterly growth basis, Sanofi has generated -28.88% fall in its net profits since last 3-months.
Sanofi’s net profit margin jumped 7% since last year same period to 21.28% in the Q3 2025. On a quarterly growth basis, Sanofi has generated -42.03% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.83 |
EPS Estimate Current Year | 0.83 |
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 0.83 - a -48.73% fall from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 0.83.
Earning Per Share (EPS) | 0 |
Sanofi’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Sanofi has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-03-31 | 0.95 | 1.02 | 7.37% |
2025-10-24 | 1.62 | 1.69 | 4.25% |
2025-07-31 | 1 | 0.91 | -9% |
2026-01-29 | 0.83 | 0 | -100% |